Automated Breast Ultrasound System Market Size, Share, Growth and Forecast (2026 - 2036)

Automated Breast Ultrasound System Market Analysis and Forecast by Fact.MR

• The global automated breast ultrasound system (ABUS) market is estimated at US$ 980.0 million in 2025 and has been forecast to expand at a CAGR of 7.1% to reach US$ 2.1 billion by 2036.
• ABUS systems are purpose-built ultrasound platforms that generate standardized, reproducible 3D volumetric images of breast tissue for cancer screening and diagnostic assessment.
• Unlike handheld ultrasound, ABUS automates probe positioning and scanning protocols to reduce operator dependency and improve examination consistency.
• The market covers automated 3D systems, handheld automated devices, and workstation platforms, with breast cancer screening as the dominant clinical application.
• Hospitals and diagnostic imaging centers form the primary buyer base.

Summary of the Automated Breast Ultrasound System Market

• Market Snapshot
  • In 2025, the global Automated Breast Ultrasound System Market was valued at approximately USD 980.0 million.
  • The market is estimated to reach USD 1.0 billion in 2026 and is projected to attain USD 2.1 billion by 2036.
  • The automated breast ultrasound system market is likely to expand at a CAGR of 7.1% during the forecast period.
  • The market is anticipated to create an absolute dollar opportunity of USD 1.0 billion between 2026 and 2036.
  • Automated Breast Ultrasound Systems accounts for 42.1% of product share in 2026.
  • USA (7.8%) and Mexico (7.4%) are the key growth markets during the forecast period.
• Demand and Growth Drivers
  • Dense breast tissue screening mandates in multiple U.S. states and growing clinical evidence supporting supplemental ultrasound are expanding ABUS adoption as a mammography adjunct.
  • Rising breast cancer screening participation rates in emerging markets are generating new demand for standardized imaging equipment that reduces operator variability.
  • AI-assisted computer-aided detection integration with ABUS systems is improving lesion identification rates and reducing radiologist interpretation time per examination.
  • Growing awareness that mammography alone has reduced sensitivity in dense breast tissue is creating clinical demand for supplemental imaging modalities including ABUS.
  • Shift from handheld breast ultrasound to automated systems improves examination reproducibility and enables comparison across serial screening visits, which is critical for interval cancer detection.
• Product and Segment View
  • Automated Breast Ultrasound Systems accounts for 42.1% of the product segment in 2026, supported by strong installed base and continued procurement across primary end use channels.
  • Hardware accounts for 37.5% of the component segment in 2026, reflecting concentrated demand across established application areas.
  • 3D Ultrasound Imaging accounts for 39.8% of the technology segment in 2026, with adoption rising across both developed and emerging markets.
  • Key segmentation includes:
    • Product: Automated Breast Ultrasound Systems, Handheld Automated Ultrasound Systems, Workstation and Imaging Systems
    • Component: Hardware, Software, Services
    • Technology: 3D Ultrasound Imaging, Artificial Intelligence Integration, Image Processing Technology
    • Application: Breast Cancer Screening, Diagnosis and Detection, Monitoring and Follow Up
  • These systems enable:
    • Targeted procurement and specification alignment across buyer segments
    • Performance benchmarking across product and application categories
    • Regional demand mapping across 30 plus countries
• Geography and Competitive Outlook
  • North America accounts for a large share of global demand, supported by established procurement channels and a mature buyer base.
  • Europe shows stable demand patterns, with Germany (7.0%) contributing through regulatory compliance and institutional procurement for automated breast ultrasound system products.
  • Asia Pacific demand is led by South Korea (6.7%) and Japan (6.5%).
  • USA (7.8%) and Mexico (7.4%) are the fastest growing country markets during the forecast period.
  • Leading companies in this market include GE HealthCare, Siemens Healthineers AG, Canon Medical Systems Corporation, FUJIFILM Healthcare Americas Corporation, SonoCiné, Inc..
• Analyst Opinion
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, says 'The automated breast ultrasound system market is at an inflection point driven by dense breast screening legislation, AI integration, and growing clinical evidence. ABUS has historically been limited by interpretation time and radiologist training requirements, but AI-assisted detection is resolving the workflow constraint that held back adoption. GE HealthCare and Siemens Healthineers lead through installed base and hospital relationships, while specialized companies compete on AI capability and clinical evidence. The expansion of dense breast notification laws from the U.S. to European and Asian markets will be the primary demand catalyst over the forecast period.'

Key Growth Drivers, Constraints, and Opportunities

Key Factors Driving Growth

• Dense breast tissue screening mandates in multiple U.S. states and growing clinical evidence supporting supplemental ultrasound are expanding ABUS adoption as a mammography adjunct.
• Rising breast cancer screening participation rates in emerging markets are generating new demand for standardized imaging equipment that reduces operator variability.
• AI-assisted computer-aided detection integration with ABUS systems is improving lesion identification rates and reducing radiologist interpretation time per examination.

Key Market Constraints

• Higher system cost and longer examination time compared to handheld ultrasound create throughput and budget concerns for high-volume screening facilities.
• Radiologist training requirements for ABUS image interpretation differ from conventional ultrasound, creating adoption barriers in facilities without dedicated breast imaging specialists.
• Reimbursement coverage for ABUS screening varies by country and payer, with inconsistent coding and payment rates limiting financial viability in some markets.

Key Opportunity Areas

• Dense breast notification legislation expanding across the U.S. and Europe is creating a regulatory tailwind for ABUS adoption as a supplemental screening modality.
• AI-powered triage systems that prioritize ABUS studies with suspicious findings are improving radiologist workflow efficiency and supporting higher screening throughput.
• Point-of-care automated breast ultrasound for mobile screening programs in underserved areas is expanding access beyond fixed radiology department installations.

Segment-wise Analysis of the Automated Breast Ultrasound System Market

• Automated Breast Ultrasound Systems holds 42.1% of the product segment in 2026, supported by established demand channels and continued procurement across primary end use applications.
• Hardware holds 37.5% of the component segment in 2026, supported by established demand channels and continued procurement across primary end use applications.
• 3D Ultrasound Imaging holds 39.8% of the technology segment in 2026, supported by established demand channels and continued procurement across primary end use applications.

The automated breast ultrasound system market is segmented by product, component, technology, application, and region.

By product, the market covers Automated Breast Ultrasound Systems, Handheld Automated Ultrasound Systems, Workstation and Imaging Systems.

By component, coverage includes Hardware, Software, Services.

Which Product Segment Dominates the Automated Breast Ultrasound System Market?

Automated Breast Ultrasound Systems is expected to account for 42.1% of the product segment in 2026. Within this category, 3D Automated Breast Ultrasound Systems, Portable Automated Breast Ultrasound Systems, Stationary Automated Breast Ultrasound Systems represent the primary sub-segments generating procurement activity. The depth of the automated breast ultrasound systems installed base across product applications sustains replacement demand and limits share erosion from newer alternatives in the automated breast ultrasound system market.

Handheld Automated Ultrasound Systems is the second largest category in the product segment, with demand concentrated in Compact Handheld Systems and Wireless Automated Ultrasound Devices. Growth in handheld automated ultrasound systems reflects shifting buyer requirements within the automated breast ultrasound system market toward this category.

Which Component Segment Dominates the Automated Breast Ultrasound System Market?

Hardware is expected to account for 37.5% of the component segment in 2026. Within this category, Ultrasound Scanners, Transducers and Probes, Display and Workstations represent the primary sub-segments generating procurement activity. The depth of the hardware installed base across component applications sustains replacement demand and limits share erosion from newer alternatives in the automated breast ultrasound system market.

Software is the second largest category in the component segment, with demand concentrated in Image Processing Software and AI Assisted Diagnosis Software. Growth in software reflects shifting buyer requirements within the automated breast ultrasound system market toward this category.

Which Technology Segment Dominates the Automated Breast Ultrasound System Market?

3D Ultrasound Imaging is expected to account for 39.8% of the technology segment in 2026. Within this category, Volumetric Imaging Systems, Real Time 3D Reconstruction represent the primary sub-segments generating procurement activity. The depth of the 3d ultrasound imaging installed base across technology applications sustains replacement demand and limits share erosion from newer alternatives in the automated breast ultrasound system market.

Artificial Intelligence Integration is the second largest category in the technology segment, with demand concentrated in Deep Learning Detection Algorithms and Computer Aided Diagnosis Systems. Growth in artificial intelligence integration reflects shifting buyer requirements within the automated breast ultrasound system market toward this category.

Which Product Trend is Shaping the Next Phase of Growth in the Automated Breast Ultrasound System Market?

AI integration is transforming the clinical workflow for automated breast ultrasound systems. Deep learning-based computer-aided detection algorithms can identify regions of interest in 3D volumetric ABUS datasets, highlight suspicious areas for radiologist review, and reduce the time required to interpret each examination from several minutes to under one minute for normal studies. This addresses one of the primary workflow bottlenecks that has limited ABUS adoption in high-volume screening programs.

The combination of automated acquisition (eliminating operator variability) and AI-assisted interpretation (reducing radiologist workload) is creating a compelling value proposition for breast imaging centers considering ABUS investment. GE HealthCare, Siemens Healthineers, and specialized companies like SonoCine are integrating AI capabilities into their ABUS platforms, and clinical validation studies are generating evidence to support regulatory clearance and reimbursement coverage for AI-assisted ABUS screening protocols.

Regional Outlook Across Key Markets

• USA is growing at 7.8%, supported by dense breast notification laws, FDA screening approval, and ABUS reimbursement codes.
• Mexico is growing at 7.4%, supported by breast screening infrastructure expansion, cancer awareness programs, and regulatory alignment.
• Germany is growing at 7.0%, supported by organized mammography screening, university clinical trials, and CE marking pathways.
• France is growing at 6.9%, supported by organized screening infrastructure, academic imaging center evaluation, and HAS assessment.

CAGR Table

Source: Fact MR (FMR) analysis, based on proprietary forecasting model and primary research.

Market Outlook for Automated Breast Ultrasound System in USA

The USA Automated Breast Ultrasound System market is projected to grow at a CAGR of 7.8% through 2036. The U.S. is the largest ABUS market globally, driven by dense breast notification laws and supplemental screening demand.

• FDA approval of ABUS for breast cancer screening as a mammography adjunct provides the regulatory foundation for clinical adoption.
• Dense breast notification legislation in over 35 states is creating direct clinical demand for supplemental breast imaging.
• CPT code 76642 and specific ABUS reimbursement codes support financial viability for imaging centers investing in ABUS technology.

Automated Breast Ultrasound System Demand Trends in Mexico

The Mexico Automated Breast Ultrasound System market is projected to grow at a CAGR of 7.4% through 2036. Mexico is an emerging ABUS market with growth linked to expanding breast cancer screening infrastructure and cancer awareness programs.

• National breast cancer screening programs are expanding access beyond mammography in underserved populations.
• Private imaging centers in major cities are adopting ABUS for supplemental screening of dense breast tissue patients.
• COFEPRIS regulatory alignment with FDA pathways facilitates ABUS system market entry.

Germany Automated Breast Ultrasound System Market Growth Outlook

The Germany Automated Breast Ultrasound System market is projected to grow at a CAGR of 7.0% through 2036. Germany is the largest European ABUS market, supported by organized breast screening programs and clinical guideline development.

• German mammography screening programs serve as a foundation for supplemental ABUS adoption in high-risk and dense tissue populations.
• University breast centers in Berlin, Munich, and Heidelberg are conducting clinical trials evaluating ABUS in screening protocols.
• TUV and CE marking pathways support timely market access for ABUS systems and AI-assisted detection software.

France Automated Breast Ultrasound System Market Demand Analysis

The France Automated Breast Ultrasound System market is projected to grow at a CAGR of 6.9% through 2036. France is a growing ABUS market with adoption supported by organized screening infrastructure and breast imaging center investment.

• National breast cancer screening programs provide institutional infrastructure for supplemental ABUS introduction.
• Academic breast imaging centers in Paris and Lyon are evaluating ABUS integration into multi-modality screening workflows.
• HAS technology assessments are evaluating clinical and economic evidence for ABUS screening reimbursement.

Automated Breast Ultrasound System Market Growth Assessment in South Korea

The South Korea Automated Breast Ultrasound System market is projected to grow at a CAGR of 6.7% through 2036. Advanced medical imaging infrastructure and high breast cancer screening rates support ABUS adoption in South Korea.

• High mammographic density prevalence in Asian women creates a strong clinical rationale for supplemental ABUS screening.
• National Cancer Screening Program infrastructure provides a channel for ABUS technology introduction.
• Samsung and domestic medical device companies are developing ABUS and AI-assisted breast imaging solutions for the local market.

Automated Breast Ultrasound System Market Opportunity Outlook in UK

The UK Automated Breast Ultrasound System market is projected to grow at a CAGR of 6.7% through 2036. The U.K. ABUS market is supported by NHS breast screening programs and research-driven adoption at academic medical centers.

• NHS Breast Screening Programme infrastructure provides a foundation for evaluating ABUS as a supplemental screening tool.
• NICE technology assessment pathways are evaluating ABUS for cost-effectiveness in dense breast tissue screening populations.
• Research collaborations between universities and imaging companies are generating clinical evidence for ABUS adoption.

Demand Landscape for Automated Breast Ultrasound System in Japan

The Japan Automated Breast Ultrasound System market is projected to grow at a CAGR of 6.5% through 2036. Japan is a growth market for ABUS driven by high mammographic density prevalence and organized screening infrastructure.

• High breast density prevalence in the Japanese population creates strong clinical demand for supplemental ultrasound screening.
• National breast cancer screening guidelines are evolving to incorporate ultrasound as a complement to mammography.
• FUJIFILM Healthcare and Canon Medical Systems have domestic ABUS development programs targeting the local market.

Competitive Benchmarking and Company Positioning

Automated Breast Ultrasound System Market Analysis By Company

• GE HealthCare, Siemens Healthineers AG, Canon Medical Systems Corporation, FUJIFILM Healthcare Americas Corporation hold established positions in the global automated breast ultrasound system market through broad product portfolios, geographic reach, and growing capabilities in higher specification categories.
• SonoCiné, Inc., Delphinus Medical Technologies, Inc., QT Imaging, Inc., CMR Naviscan Corporation participate across specific price tiers, end use segments, and regional channels, with competition shaped by product quality, service support, and distribution access.
• 3D volumetric image quality, AI-assisted detection algorithm accuracy, and integration with existing mammography PACS workflows are the primary competitive differentiators, with FDA and CE clearance for AI-assisted screening creating a regulatory moat for early entrants.

GE HealthCare leads the global ABUS market through its Invenia ABUS platform and broad breast imaging portfolio. Siemens Healthineers AG holds a strong position with its ACUSON ABUS system. Canon Medical Systems Corporation and FUJIFILM Healthcare serve specific regional markets. SonoCine, Inc. and Delphinus Medical Technologies represent specialized ABUS-focused companies with differentiated technology approaches.

The market is concentrated among large medical imaging companies with established breast imaging portfolios, supplemented by specialized ultrasound companies targeting the ABUS niche. Competition is shaped by FDA clearance scope, AI detection capability, and imaging center workflow integration. The regulatory pathway for AI-assisted ABUS screening creates a significant barrier to entry for companies without clinical validation data and regulatory experience.

Key Companies in the Automated Breast Ultrasound System Market

• GE HealthCare, Siemens Healthineers AG, Canon Medical Systems Corporation, FUJIFILM Healthcare Americas Corporation are among the leading players in the automated breast ultrasound system market globally, supported by strong brand visibility and broad product portfolios.
• SonoCiné, Inc., Delphinus Medical Technologies, Inc., QT Imaging, Inc., CMR Naviscan Corporation hold established positions across specific categories, supported by durable products and regional distribution.

Recent Industry Developments

• GE HealthCare - AI-Assisted ABUS Detection (January 2026)
  • GE HealthCare received FDA clearance for an AI-powered computer-aided detection module for its automated breast ultrasound system, improving lesion identification in dense breast tissue screening.
• Siemens Healthineers AG - Portable ABUS Platform (2025)
  • Siemens Healthineers AG introduced a compact, portable automated breast ultrasound system targeting mobile screening programs and smaller breast imaging centers with space and budget constraints.
• Canon Medical Systems Corporation - Cloud ABUS Workflow (2025)
  • Canon Medical Systems Corporation launched a cloud-based ABUS image management and AI-assisted triage platform, enabling radiologists to review automated breast ultrasound studies remotely with AI-prioritized worklists.
• FUJIFILM Healthcare Americas Corporation - Dense Breast Screening Program (February 2026)
  • FUJIFILM Healthcare Americas Corporation partnered with a national breast cancer screening organization to deploy ABUS systems in underserved communities with high dense breast tissue prevalence.

Leading Companies Shaping the Automated Breast Ultrasound System Market

• GE HealthCare
• Siemens Healthineers AG
• Canon Medical Systems Corporation
• FUJIFILM Healthcare Americas Corporation
• SonoCiné, Inc.
• Delphinus Medical Technologies, Inc.
• QT Imaging, Inc.
• CMR Naviscan Corporation
• FUJIFILM Healthcare
• SuperSonic Imagine (Hologic, Inc.)

Sources and Research References

• GE HealthCare. Product portfolio and corporate announcements.
• Siemens Healthineers AG. Product portfolio and corporate announcements.
• Canon Medical Systems Corporation. Product portfolio and corporate announcements.
• Industry association statistics, regulatory publications, trade databases, and company product catalogs.
• Primary interviews with manufacturers, distributors, buyers, and institutional users.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

Key Questions This Report Addresses

What is the current and future size of the Automated Breast Ultrasound System Market?

• How fast is the Automated Breast Ultrasound System Market expected to grow between 2026 and 2036?
• Which product is likely to lead the market by 2026?
• Which component segment is expected to account for the highest demand by 2026?
• What factors are driving demand in this market globally?
• How is technology adoption influencing the market structure?
• Which countries are projected to show the fastest growth through 2036?
• What is driving market expansion in USA and Mexico?
• Who are the key companies active in the Automated Breast Ultrasound System Market?
• How does Fact.MR estimate and validate the market forecast?

Automated Breast Ultrasound System Market Definition

The automated breast ultrasound system market covers products, technologies, and services associated with product, component, technology categories. The scope includes global and regional market size and forecasts for 2026 to 2036 across product, component, technology, application, and region.

Automated Breast Ultrasound System Market Inclusions

• The scope covers global and regional market size and forecasts for 2026 to 2036 across product, component, technology, application, and region.
• It includes regional demand analysis across major geographies, based on factors such as technology adoption, regulatory requirements, institutional spending, and commercial demand patterns.
• The report includes pricing and cost analysis across entry-level, mid-range, and premium categories, including hardware, software, and service components where applicable.
• It covers technology trends, market drivers and constraints, and the competitive landscape, including product portfolios, pricing strategy, geographic reach, and distribution expansion of leading players.

Automated Breast Ultrasound System Market Exclusions

• The scope excludes adjacent categories, general-purpose alternatives, and products not specifically classified under the automated breast ultrasound system market taxonomy.
• It excludes custom-built in-house solutions, informal unbranded products with low market visibility, and rental or leasing services without direct product sales.
• The report excludes military or defense-grade variants, industrial systems outside the defined scope, and non-commercial applications without market transaction data.
• It also excludes software-only platforms sold independently from hardware, unless they are part of the defined product or service taxonomy.

Automated Breast Ultrasound System Market Research Methodology

• The methodology combines secondary research, primary interviews, and forecast modelling.
• It draws on 120 plus secondary sources and benchmarks 65 plus company product portfolios.
• Market sizing covers 30 plus countries through a demand-side model, supported by top-down validation.
• Key inputs include end use adoption rates, technology penetration, pricing benchmarks, and regional procurement patterns.
• The model cross-checks demand with shipments, pricing trends, channel mix, and product launches.
• Primary validation includes 25 plus interviews across manufacturers, distributors, buyers, and institutional users.
• Final estimates go through trade-flow checks, sales-pattern review, and sensitivity testing.